Journal profile · Pharmacology & Pharmacy
Journal of Pharmacy and Pharmacology
ISSN 0022-3573 · eISSN 2042-7158 · Wiley-Blackwell · ENGLAND · Monthly · Founded 1949
Journal of Pharmacy and Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.62; hybrid open access; APC about USD 3,839; median 110 days to acceptance (108 articles, last 24 months); community-reported acceptance: about 75%; 137 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacy and Pharmacology is published by Wiley-Blackwell and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Receptor Mechanisms and Signaling, Drug Solubulity and Delivery Systems and Drug Transport and Resistance Mechanisms, together about 21% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
JPP keeps pace with new research on how drug action may be optimized by new technologies, and attention is given to understanding and improving drug interactions in the body. At the same time, the Journal maintains its established and well-respected core strengths in areas such as pharmaceutics and drug delivery, experimental and clinical pharmacology, biopharmaceutics and drug disposition, and drugs from natural sources. JPP publishes at least one special issue on a topical theme each year.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief David S. JonesPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 3, United States 1, Italy 1, Australia 1 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology7.6%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7%
- Drug Transport and Resistance MechanismsMedicine6.4%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.4%
- Analytical Methods in PharmaceuticalsChemistry5.9%
- Analytical Chemistry and ChromatographyChemistry5.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience5.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: OCLC
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.62LetPub ·
- Impact factor (publisher) 2025
- 6.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.7Publisher website ·
- CiteScore 2026-06
- 6.7LetPub ·
- CiteScore (publisher) 2025
- 6.7Publisher website ·
- SJR 2026-06
- 0.77LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 107LetPub ·
- h-index
- 185OpenAlex ·
- i10-index
- 9,132OpenAlex ·
- 2-year mean citedness
- 3.4OpenAlex ·
- Self-citation rate
- 2.7%LetPub ·
- Share of gold OA articles
- 13.9%LetPub ·
Volume
- Articles per year
- 125LetPub ·
- Downloads per year (publisher) 2025
- 341,739Publisher website ·
Articles by year OpenAlex count · 18,612 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 109 | 8 | 27 |
| 2025 | 137 | 24 | 308 |
| 2024 | 158 | 90 | 1,040 |
| 2023 | 125 | 71 | 1,435 |
| 2022 | 96 | 22 | 1,234 |
| 2021 | 240 | 42 | 3,896 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
110 daysMedian, submission to acceptance · P25–P75 86 days – 145 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 108 articles with submission and acceptance dates (324 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision 2025
- 4 daysPublisher website ·
- Submission to final decision 2025
- 4 daysPublisher website ·
- Acceptance to publication
- 36 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 2,911 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access options
JPP offers authors the option of publishing under a standard licence or an open access licence. There is no charge to publish under a standard licence. If publishing open access, authors will need to pay an open access charge. Details of the open access licences and open access charges. Oxford University Press (OUP) has a growing number of Read and Publish agreements with institutions and consorti…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1949
- ISSN
- 0022-3573
- Electronic ISSN
- 2042-7158
- Latest issue on the website
- Volume 78, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Pharmacy and Pharmacology
What CAS zone is Journal of Pharmacy and Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacy and Pharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmacy and Pharmacology?
The latest impact factor listed by LetPub is 3.62; CiteScore 6.7, h-index 185.
How long does peer review take at Journal of Pharmacy and Pharmacology?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 86–145 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Pharmacy and Pharmacology based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (3), United States (1) and Italy (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmacy and Pharmacology?
According to LetPub and DOAJ records, Journal of Pharmacy and Pharmacology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Journal of Pharmacy and Pharmacology open access, and what is the APC?
Journal of Pharmacy and Pharmacology is a hybrid journal. For open-access publication: APC about USD 3,839.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .